Front Endocrinol (Lausanne). 2026 Mar 6;17:1744691. doi: 10.3389/fendo.2026.1744691. eCollection 2026.
ABSTRACT
BACKGROUND: Maturity-onset diabetes of the young type 2 (GCK-MODY), caused by heterozygous inactivating mutations in the glucokinase (GCK) gene, is generally considered a mild and stable form of diabetes with a relatively low risk of chronic complications. However, whether GCK deficiency predisposes to retinal microvascular injury under metabolic stress remains unclear.
METHODS: A GCK-Q26L knock-in mouse model (GCKMut) was used to evaluate age- and diet-dependent alterations in retinal morphology and molecular pathology under normal diet (ND) and high-fat diet (HFD) conditions at 28, 40, and 60 weeks. Retinal structure and vasculature were examined by H&E staining and trypsin digestion. Oxidative stress, inflammation, and apoptosis were assessed using dihydroethidium fluorescence, Western blotting, and immunohistochemistry. Correlation analyses were performed to determine the relationship between NOX2 expression and inflammatory/apoptotic markers.
RESULTS: Under ND, retinal morphology and microvasculature were comparable between GCKMut and WT mice at 28, 40, and 60 weeks. In contrast, after prolonged HFD exposure, 60-week-old GCKMut mice exhibited clear microvascular injury, characterized by increased acellular capillaries and pronounced pericyte loss. At this late stage, retinal ROS levels were elevated, accompanied by NOX2 upregulation and increased expression of IL-1β and TNF-α. Apoptotic signaling was concurrently enhanced, as reflected by increased cleaved caspase-3 and a higher Bax/Bcl-2 ratio. Consistently, NOX2 protein levels correlated positively with inflammatory and apoptotic markers.
CONCLUSIONS: This study demonstrates that GCK inactivation can predispose to retinal microvascular injury under prolonged metabolic stress. These findings support a NOX2-centered oxidative stress-linked inflammatory and apoptotic axis in late-stage retinal injury and highlight potential therapeutic targets for risk reappraisal in GCK-MODY.
PMID:41869024 | PMC:PMC13002402 | DOI:10.3389/fendo.2026.1744691